21.89
1.32 (6.42%)
1.32 (6.42%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.32 | 6.42% | 21.89 | 19:32:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.29 | 21.113 | 22.20 | 21.89 | 20.57 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 21.90 | 22.70 | 0.80 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,593 | 422,238 | $ 21.69 | $ 9,157,514 | 348,511 | 10.30 - 33.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:48:14 | formt | 100 | $ 21.89 | USD |
Kiniksa Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.49B | 68.08M | 28.06M | $ - | $ - | -3.01 | -7.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -100.00k | 0.30% |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 23.97 | 24.70 | 19.8292 | 21.98 | 429,149 | -2.08 | -8.68% |
| 1 Month | 20.30 | 24.70 | 19.61 | 22.06 | 357,058 | 1.59 | 7.83% |
| 3 Months | 17.21 | 24.70 | 16.65 | 20.12 | 342,704 | 4.68 | 27.19% |
| 6 Months | 17.67 | 24.70 | 14.51 | 18.30 | 382,368 | 4.22 | 23.88% |
| 1 Year | 18.38 | 33.00 | 10.30 | 18.99 | 352,134 | 3.51 | 19.1% |
| 3 Years | 24.45 | 33.00 | 5.01 | 17.60 | 221,407 | -2.56 | -10.47% |
| 5 Years | 24.45 | 33.00 | 5.01 | 17.60 | 221,407 | -2.56 | -10.47% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, KPL-045, KPL-404 are other monoclonal antibodies. |
